132 related articles for article (PubMed ID: 7004772)
1. Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Oct; 22(4):341-7. PubMed ID: 7004772
[TBL] [Abstract][Full Text] [Related]
2. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
[TBL] [Abstract][Full Text] [Related]
3. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
4. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
5. Failure to induce early abortion by huge doses of a superactive LRH agonist in women.
Skarin G; Nillius SJ; Wide L
Contraception; 1982 Nov; 26(5):457-63. PubMed ID: 6819111
[TBL] [Abstract][Full Text] [Related]
6. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
7. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
8. Failure to interrupt established pregnancy in humans by D-tryptophan-6-luteinizing hormone-releasing hormone.
Tolis G; Comaru-Schally AM; Mehta AE; Schally AV
Fertil Steril; 1981 Aug; 36(2):241-2. PubMed ID: 6455307
[TBL] [Abstract][Full Text] [Related]
9. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
Lemay A; Faure N; Labrie F; Fazekas AT
Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
[TBL] [Abstract][Full Text] [Related]
10. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
11. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
Skarin G; Nillius SJ; Wide L
Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey.
Webley GE; Hodges JK; Given A; Hearn JP
J Endocrinol; 1991 Jan; 128(1):121-9. PubMed ID: 1900320
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
15. [Clinical observations on LRH-A used for contraception by luteolysis in normal women--analysis of 88 cases].
Lu RK; Chen HY; Liu Y; Zhang L; He YJ; Ge LJ; Yuan XW; Qui XD
Shengzhi Yu Biyun; 1987; 7(1):39-40, 45-7. PubMed ID: 12341309
[TBL] [Abstract][Full Text] [Related]
16. Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility.
Sheehan KL; Casper RF; Yen SS
Fertil Steril; 1982 Feb; 37(2):209-12. PubMed ID: 7037463
[TBL] [Abstract][Full Text] [Related]
17. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
Arrata WS; Chatterton RT
Am J Obstet Gynecol; 1974 Dec; 120(7):954-9. PubMed ID: 4429112
[TBL] [Abstract][Full Text] [Related]
18. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM; Thompson IE; Taymor ML
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[TBL] [Abstract][Full Text] [Related]
19. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
Jeppsson S; Rannevik G; Thorell JI
Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
[TBL] [Abstract][Full Text] [Related]
20. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
